爱尔兰医疗保健与哈钦森住宅合并调查
SOURCE / GOV.UK-CMA Updates · Healthcare Ireland / Hutchinson Homes merger inquiry
原文
Healthcare Ireland / Hutchinson Homes merger inquiry
完整原文
<h2 id="statutory-timetable">Statutory timetable</h2> <table> <thead> <tr> <th scope="col">Date</th> <th scope="col">Action</th> </tr> </thead> <tbody> <tr> <td>TBC</td> <td>Deadline for phase 1 decision</td> </tr> <tr> <td>TBC</td> <td>Launch of merger inquiry</td> </tr> <tr> <td>TBC</td> <td>Invitation to comment</td> </tr> <tr> <td>2 June 2026</td> <td>Initial enforcement order (*)</td> </tr> </tbody> </table> <p>(*) The CMA has made an initial enforcement order. This case page will be updated when the CMA formally commences its phase 1 investigation.</p> <h2 id="phase-1">Phase 1</h2> <h3 id="initial-enforcement-order">Initial enforcement order</h3> <p>3 June 2026: The CMA has revoked and reissued the interim enforcement order imposed on 2 June 2026 in relation to the completed acquisition by Y3 Holdings Limited of Hutchinson Homes Limited.</p> <ul> <li> <span id="attachment_aeb85fae-898f-443f-88d7-8df0d78c2f4f" class="attachment-inline"><a href="https://assets.publishing.service.gov.uk/media/6a203a1731d692299df80d16/revocation_order.pdf">Revocation order (PDF, 101KB)</a></span> (4.6.26)</li> <li> <span id="attachment_0c3cdc89-932c-4df7-98d2-4bbdd31c68bf" class="attachment-inline"><a href="https://assets.publishing.service.gov.uk/media/6a204aac178cd408c8f80d15/0306_initial_enforcement_order.pdf">Initial enforcement order (3 June 2026) (PDF, 204KB)</a></span> (4.6.26)</li> </ul> <p>2 June 2026: The CMA has served an initial enforcement order under section 72(2) of the Enterprise Act 2002 on Y3 Holdings Limited, Healthcare Ireland Holdings Limited, Healthcare Ireland Limited, HCI Bidco 2 Limited and Hutchinson Homes Limited.</p> <ul> <li> <span id="attachment_130cce78-663e-4719-ab37-8f6e08843efd" class="attachment-inline"><a href="https://assets.publishing.service.gov.uk/media/6a2039ea730aece621f098a0/0206_initial_enforcement_order.pdf">Initial enforcement order (2 June 2026) (PDF, 204KB)</a></span> (4.6.26)</li> </ul> <h3 id="amendments-and-consents-granted">Amendments and consents granted</h3> <ul> <li> <span id="attachment_81c80a7c-4ceb-43e8-a50c-e27cce6f8e7f" class="attachment-inline"><a href="https://assets.publishing.service.gov.uk/media/6a3b8f674c7605ab5672389e/Derogation_18_June_2026.pdf">Derogation 18 June 2026 (PDF, 161KB)</a></span> (24.6.26)</li> <li> <span id="attachment_eb5bbe2a-6394-4cab-be8e-195e42c1457f" class="attachment-inline"><a href="https://assets.publishing.service.gov.uk/media/6a3b8f8233bc5beefd3c481a/Derogation_22_June_2026.pdf">Derogation 22 June 2026 (PDF, 166KB)</a></span> (24.6.26)</li> </ul> <h2 id="contact">Contact</h2> <p>Send written representations about any competition issues to:</p> <ul> <li><a href="mailto:healthcareireland.hutchinsoncarehomes@cma.gov.uk">healthcareireland.hutchinsoncarehomes@cma.gov.uk</a></li> <li>Principal Case Officer, Marta Freire, <a href="mailto:marta.freire@cma.gov.uk">marta.freire@cma.gov.uk</a>, 020 3738 6485</li> <li>Case Officer, Stephenie Lau, <a href="mailto:stephenie.lau@cma.gov.uk">stephenie.lau@cma.gov.uk</a>, 020 3738 6696</li> </ul> <h3 id="privacy-notice">Privacy notice</h3> <p>Your name and contact details are your personal data. In collecting, receiving, storing, accessing and using your personal data, the CMA, as controller, is processing your personal data. The CMA processes personal data in accordance with data protection law. The CMA is processing your personal data so that it can contact you again, should it need further help or information from you, in order to carry out its merger work under Part 3 of the Enterprise Act 2002. For more information about how the CMA processes personal data and your rights relating to that data, please read our <a href="https://www.gov.uk/government/organisations/competition-and-markets-authority/about/personal-information-charter">privacy notice</a>.</p>
归纳
爱尔兰竞争监管机构对Healthcare Ireland与Hutchinson Homes的合并交易展开调查。该调查旨在评估合并是否可能显著削弱市场竞争，特别是在相关医疗保健和住宅服务领域。监管机构将审查交易对消费者选择、价格及服务质量的影响，并考虑潜在的反竞争效应。调查结果将决定是否批准、附加条件或禁止该合并。
点评
该调查凸显医疗与住宅服务跨界合并中市场界定与竞争影响评估的复杂性，可能为类似混合合并的反垄断审查提供先例。
法律视角点评
AI 生成 · 人工审核核心关切
该调查凸显医疗与住宅服务跨界合并中市场界定与竞争影响评估的复杂性，可能为类似混合合并的反垄断审查提供先例。
实务启示
中国法律人应关注跨界合并中相关市场界定方法，以及监管机构如何平衡消费者选择、价格与服务质量的多维竞争效应。